Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SNTI

+ Watchlist+ Portfolio

Senti Biosciences, Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.10
52-Week Range
$0.09 – $95.04
Market Cap
$225.95K
P/E (TTM)
—
EPS (TTM)
-46.20
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
-71.16%
Gross Margin
0.00%
Operating Margin
-62343.24%
Profit Margin
0.00%
Current Ratio
0.54
Debt/Equity
—
Total Debt
$21.56M
Free Cash Flow
$-21.57M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$262.07M

Market Snapshot

About

Senti Biosciences is a clinical-stage biotechnology company developing next-generation cell and gene therapies using synthetic biology. The company designs programmable cellular therapies that can sense disease-specific signals and respond with precision therapeutic action. Senti is advancing multiple programs in oncology and immunology.